| 000 | 01334 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514020114.0 | ||
| 264 | 0 | _c20020206 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a1471-2598 | ||
| 024 | 7 |
_a10.1517/14712598.1.4.733 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSunder-Plassmann, G | |
| 245 | 0 | 0 |
_aThe clinical potential of novel erythropoiesis stimulating protein. _h[electronic resource] |
| 260 |
_bExpert opinion on biological therapy _cJul 2001 |
||
| 300 |
_a733-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnemia _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aDarbepoetin alfa |
| 650 | 0 | 4 |
_aErythropoietin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHemoglobins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aReceptors, Erythropoietin _xmetabolism |
| 650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
| 700 | 1 | _aHörl, W H | |
| 773 | 0 |
_tExpert opinion on biological therapy _gvol. 1 _gno. 4 _gp. 733-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14712598.1.4.733 _zAvailable from publisher's website |
| 999 |
_c11641550 _d11641550 |
||